Stimulant Use in Adolescent ADHD is Associated with Attenuated and Distinct Cortical Differences

Brisbane Convention & Exhibition Centre 

Over six million children have been diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) in the U.S., making it the most prevalent neurodevelopmental disorder.^1,2 Pharmacologic management of ADHD is the first-line treatment approach, aimed at mitigating behavioral symptoms, and is hypothesized to "normalize" brain structure.^3,4 However, research on the potential impacts of ADHD medications on brain phenotypes has been limited by small, homogeneous samples, leading to inconsistent and often null findings regarding affected brain regions.⁴